Profusa regains Nasdaq compliance; faces one-year equity-rule monitoring

Profusa, Inc.

Received Nasdaq letter Sept 9, 2026 confirming compliance with Bid Price Rule 5550(a)(2) and Equity Rule 5550(b)(1).
Subject to one-year Mandatory Panel Monitor; any future Equity Rule noncompliance triggers delist determination, no compliance plan allowed.
Company may appeal delist determination via Nasdaq hearing; intends to continue monitoring compliance.
Press release also references previously announced Option Agreement to acquire G3 Vision Labs, Inc.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.